MPPW
TECH icon

Mitchell & Pahl Private Wealth’s Bio-Techne TECH Stock Holding History

Mitchell & Pahl Private Wealth’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,668
Closed -$216K – 171
2021
Q4 		$216K Hold
1,668
– – 0.14% 158
2021
Q3 		$202K Buy
+1,668
New +$203K 0.15% 154

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Mitchell & Pahl Private Wealth's TECH Position: Q1 2022 in Review

Mitchell & Pahl Private Wealth sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 1,668 shares — an estimated $216K sold.

Mitchell & Pahl Private Wealth first reported a position in TECH in Q3 2021 and held it in 2 quarters. The position peaked at $216K in Q4 2021. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

  • Mitchell & Pahl Private Wealth reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
  • Mitchell & Pahl Private Wealth sold 1,668 Bio-Techne shares in Q1 2022, an estimated $216K.
  • Mitchell & Pahl Private Wealth first reported a position in Bio-Techne in Q3 2021 and held it in 2 quarters.
  • Mitchell & Pahl Private Wealth's Bio-Techne position peaked at $216K in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q1 2022, filed 14 Apr 2022.